Educational Program & Breakfast

• **Not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina 2022 or its accredited provider.

Welcome and Announcements

Interesting Diagnoses made by OCT

• Steve Yeh, MD

Q&A

Imaging Features to Evaluate PCV

• Gemmy Cheung, FRCOphth

Q&A

Diagnosis and Evaluation of GA and Precursor Lesions in AMD

• Elias Reichel, MD

Q&A

Imaging Pearls for Uveitis

• Yasha S. Modi, MD

Q&A

Retinal Imaging: Not Always Clinically Relevant in DME

• Sophie J. Bakri, MD

Q&A

CRVO: What a Photo Can Tell You? New Understandings from Imaging Modalities and How to Optimize Patient Outcomes

• Varun Chaudhary, MD

Q&A

Refreshments and Networking in the Exhibit Hall

The Impact of Twitter Use Among Academic Ophthalmologists

• Sunir J. Garg, MD, FACS

Q&A

Lifetime Fluorescence Imaging

• Rishi P. Singh, MD

Q&A

Home Monitoring to Detect Onset of CNV: Today and Tomorrow

• Susan B. Bressler, MD

Q&A

Recent Challenges of Artificial Intelligence in Retinal Disease

• Neil M. Bressler, MD

Q&A

Refreshments and Networking in the Exhibit Hall

Panel Discussion

• Moderator: Peter K. Kaiser, MD
  Panelists: Robert L. Avery, MD; Neil M. Bressler, MD; Susan B. Bressler, MD; Glenn J. Jaffe, MD; Judy E. Kim, MD; Elias Reichel, MD

Educational Program & Lunch

Practical Training in Equipment, Technology, and Insurance

• **Not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina 2022 or its accredited provider.

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

Educational Program & Breakfast

Welcome and Announcements

Non-Exudative CNVM: What to Look for and How to Manage Them?

• Varun Chaudhary, MD

Q&A

Pegcetacoplan DERBY and OAKS Phase 3 Study Results

• Caroline R. Baumal, MD, FASRS

Q&A

Biosimilars in Retinal Disease

• Susan B. Bressler, MD

Q&A

CATT in 2022: Are the Results Still Relevant?

• Glenn J. Jaffe, MD

Q&A

Long-term Outcomes in the Treatment of Neovascular AMD: What We Know and What We Don’t Know

• Daniel F. Martin, MD

Q&A

Long-term Follow-up of EVEREST II and PLANET Study Participants

• Gemmy Cheung, FRCOphth

Q&A

Refreshments and Networking in the Exhibit Hall

Faricimab for nAMD Phase 3 TENAYA and LUCERNE Studies

• Rishi P. Singh, MD

Q&A

Update on the Port Delivery System for nAMD

• Carl D. Regillo, MD

Q&A

Gene Therapy for Exudative AMD

• Lejla Vajzovic, MD

Q&A

Aqueous Chlorhexidine Compared with Povidone-iodine as Ocular Antisepsis before Intravitreal Injection: A Randomized Clinical Trial

• Sunir J. Garg, MD, FACS

Q&A

Refreshments and Networking in the Exhibit Hall

Panel Discussion

• Moderator: Carl D. Regillo, MD
  Panelists: Robert L. Avery, MD; Susan B. Bressler, MD; Sunir J. Garg, MD, FACS; Glenn J. Jaffe, MD; Daniel F. Martin, MD; Basil K. Williams Jr, MD

Educational Program & Lunch

Practical Training in Equipment, Technology, and Insurance

• This session is not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina 2022 or its accredited provider.

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

Education Program & Breakfast

Welcome and Announcements

Diabetic Tractional Detachments: Surgical Management Tips

• Rishi P. Singh, MD

Q&A

Diabetic Retinopathy Screening: A Different Approach

• Yasha S. Modi, MD

Q&A

Update on Brolucizumab for DME

• Michael S. Ip, MD

Q&A

Diabetic Macular Ischemia: A New Treatment Endpoint?

• Gemmy Cheung, FRCOphth

Q&A

Continuous or Noncontinuous DME Treatment: What does the Evidence Show?

• Varun Chaudhary, MD

Q&A

Treatment for RVO: Does Fluid Status Matter?

• Michael S. Ip, MD

Q&A

Refreshments and Networking in the Exhibit Hall

Vitreous Hemorrhage From PDR: Vitrectomy or Anti-VEGF

• Neil M. Bressler, MD

Q&A

Anti-VEGF Prevention for Severe NPDR: A tale of Two Perspectives

• Neil M. Bressler, MD

Q&A

Future Directions of the DRCR Retina Network

• Daniel F. Martin, MD

Q&A

Lapses in Care While Managing PDR

• Susan B. Bressler, MD

Q&A

Refreshments and Networking in the Exhibit Hall

Retinal Vascular Disease Panel Discussion

• Moderator: Michael S. Ip, MD
  Panelists: Robert L. Avery, MD; Neil M. Bressler, MD; Varun Chaudhary, MD; Gemmy Cheung, FRCOphth; Yasha S. Modi, MD; Judy E. Kim, MD

Educational Program & Lunch

Practical Training in Equipment, Technology, and Insurance

• This session is not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina 2022 or its accredited provider.

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

Educational Program & Breakfast

• **This session is not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina 2022 or its accredited provider.

Welcome and Announcements

Surgical Management of Pediatric Retinal Detachment

• Caroline R. Baumal, MD, FASRS

Q&A

Pediatric Epiretinal Membranes: Differential Diagnosis and Management

• Lejla Vajzovic, MD

Q&A

Management of Pediatric and Adult-onset Coats Disease

• Caroline R. Baumal, MD, FASRS

Q&A

What Do We Expect to See after Radiation for Choroidal Melanoma

• Basil K. Williams Jr, MD

Q&A

Retinal Side Effects after Chemotherapy

• William F. Mieler, MD

Q&A

Indications and Approach to Biopsy of Intraocular Tumors

• Basil K. Williams Jr, MD

Q&A

Refreshments and Networking in the Exhibit Hall

Do Not Miss These Diagnoses!

• Steven Yeh, MD

Q&A

Presentation Coming Soon!

• Speaker Coming Soon!

Q&A

My Best Uveitis Cases

• Glenn J. Jaffe, MD

Q&A

Learn from My Mistakes in Uveitis Cases

• Sunil K. Srivastava, MD

Q&A

Refreshments and Networking in the Exhibit Hall

Inherited Retinal Disease Fascinomas

• Elias Reichel, MD

Q&A

Practical Considerations for Subretinal Gene Therapy Delivery

• Lejla Vajzovic, MD

Q&A

What’s the Right Dose of Anti-VEGF for Pediatric Patients?

• Robert L. Avery, MD

Q&A

Update on Gene Therapy for Inherited Retinal Disease

• Lejla Vajzovic, MD

Q&A

Educational Program & Lunch

Announcement Coming Soon!

• *This session is not approved for AMA PRA Category 1 Credit(s)™.

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

Join your colleagues on a journey through the legends and history of Hawaii complete with stories, drumbeats, folk music, hula dancing and fire performers. This event is open to all attendees and their guests; an additional fee is required – please register directly with the resort (select Thursday, January 20, 2022 to be with our group).

• *This session is not approved for AMA PRA Category 1 Credit(s)™.

Educational Program & Breakfast

Welcome and Announcements

Hypersonic Vitrectomy

• Sunir J. Garg, MD, FACS

Q&A

Macular Holes: When Are We Doing Too Much? When Are We Doing Too Little?

• Varun Chaudhary, MD

Q&A

Management of Submacular Hemorrhage

• Sophie J. Bakri, MD

Q&A

Controversies in the Management of Posterior Segment Open-globe Injuries

• William F. Mieler, MD

Q&A

Vitreoretinal Surgery Techniques for Infectious and Inflammatory Retinal Diseases

• Sunil K. Srivastava, MD

Q&A

Techniques for PVR Surgery

• Carl D. Regillo, MD

Q&A

Refreshments and Networking in the Exhibit Hall

Panel Discussion

• Moderator: Sophie J. Bakri, MD
  Panelists: Sunir J. Garg, MD, FACS; William F. Mieler, MD; Sunil K. Srivastava, MD; Lejla Vajzovic, MD; Steven Yeh, MD

Refreshments and Networking in the Exhibit Hall

Case Presentations and Panel Discussion

• Moderator: Sophie J. Bakri, MD
  Panelists: Caroline R. Baumal, MD, FASRS; Glenn J. Jaffe, MD; William F. Mieler, MD; Sunil K. Srivastava, MD; Steven Yeh, MD

Meeting Concludes